About Insmed Incorporated - INSM
Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing treatments for patients with serious and rare diseases, particularly in the areas of lung and infectious diseases. Their portfolio often includes therapies aimed at addressing unmet medical needs and improving patient quality of life.
What are Insmed Incorporated's core values and mission statement?
Insmed Incorporated's mission is to transform the lives of patients with serious and rare diseases by developing and delivering innovative therapies. Their core values center on passion for the patient, scientific rigor, integrity, and teamwork.
Who founded Insmed Incorporated and when?
Insmed Incorporated was founded by Robert A. Biesecker in 1999.
Who leads Insmed Incorporated?
As of the last update before my latest knowledge cutoff, William Lewis was the Chairman and Chief Executive Officer of Insmed Incorporated.
Where is Insmed Incorporated located, and what is its base country?
Insmed Incorporated is located in Bridgewater, New Jersey, USA, which is also its base country.
On which exchanges is Insmed Incorporated traded?
Insmed Incorporated is traded on the NASDAQ Stock Market under the ticker symbol "INSM."
Insmed Incorporated (INSM) Price Live Data
The live price of Insmed Incorporated (INSM) is $28.93, with a trading volume of 349,701 in the last 24 hours. Wrapstocks updates the INSM price in real-time. Insmed Incorporated is down -1.58% in the last 24 hours. The company has a live market cap of $4,138,783,744.00 and a supply of 143,062,003 INSM stocks.
Insmed Incorporated (INSM) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 4 hours and 54 minutes.